Back to Search
Start Over
Tumor BRCA mutation or high genomic LOH identify ovarian cancer patients likely to respond to rucaparib: Interim results for ARIEL2 clinical trial.
- Source :
-
Gynecologic Oncology . May2015 Supplement 1, Vol. 138, p4-4. 1p. - Publication Year :
- 2015
Details
- Language :
- English
- ISSN :
- 00908258
- Volume :
- 138
- Database :
- Academic Search Index
- Journal :
- Gynecologic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 102976185
- Full Text :
- https://doi.org/10.1016/j.ygyno.2015.04.024